Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine.
Topaz N, Kristiansen PA, Schmink S, Congo-Ouédraogo M, Kambiré D, Mbaeyi S, Paye M, Sanou M, Sangaré L, Ouédraogo R, Wang X. Topaz N, et al. Among authors: congo ouedraogo m. Microb Genom. 2020 Dec;6(12):mgen000486. doi: 10.1099/mgen.0.000486. Epub 2020 Dec 11. Microb Genom. 2020. PMID: 33332261 Free PMC article.
Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
Kambiré D, Soeters HM, Ouédraogo-Traoré R, Medah I, Sangare L, Yaméogo I, Sawadogo G, Ouédraogo AS, Hema-Ouangraoua S, McGee L, Srinivasan V, Aké F, Congo-Ouédraogo M, Sanou S, Ba AK, Novak RT, Van Beneden C; MenAfriNet Consortium. Kambiré D, et al. Among authors: congo ouedraogo m. PLoS One. 2016 Nov 10;11(11):e0166384. doi: 10.1371/journal.pone.0166384. eCollection 2016. PLoS One. 2016. PMID: 27832151 Free PMC article.
Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.
Kambiré D, Soeters HM, Ouédraogo-Traoré R, Medah I, Sangaré L, Yaméogo I, Sawadogo G, Ouédraogo AS, Ouangraoua S, McGee L, Srinivasan V, Aké F, Congo-Ouédraogo M, Ky Ba A, Whitney CG, Novak RT, Van Beneden C; MenAfriNet Consortium. Kambiré D, et al. Among authors: congo ouedraogo m. J Infect. 2018 Mar;76(3):270-279. doi: 10.1016/j.jinf.2017.12.002. Epub 2017 Dec 15. J Infect. 2018. PMID: 29253559 Free PMC article.
Molecular characterization of invasive meningococcal isolates in Burkina Faso as the relative importance of serogroups X and W increases, 2008-2012.
Retchless AC, Congo-Ouédraogo M, Kambiré D, Vuong J, Chen A, Hu F, Ba AK, Ouédraogo AS, Hema-Ouangraoua S, Patel JC, Traoré RO, Sangaré L, Wang X. Retchless AC, et al. Among authors: congo ouedraogo m. BMC Infect Dis. 2018 Jul 18;18(1):337. doi: 10.1186/s12879-018-3247-x. BMC Infect Dis. 2018. PMID: 30021533 Free PMC article.
Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.
Soeters HM, Kambiré D, Sawadogo G, Ouédraogo-Traoré R, Bicaba B, Medah I, Sangaré L, Ouédraogo AS, Ouangraoua S, Yaméogo I, Congo-Ouédraogo M, Ky Ba A, Aké F, Srinivasan V, Novak RT, McGee L, Whitney CG, Van Beneden C. Soeters HM, et al. Among authors: congo ouedraogo m. J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S253-S262. doi: 10.1093/infdis/jiz301. J Infect Dis. 2019. PMID: 31671444 Free PMC article.
Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys.
Mbaeyi S, Sampo E, Dinanibè K, Yaméogo I, Congo-Ouédraogo M, Tamboura M, Sawadogo G, Ouattara K, Sanou M, Kiemtoré T, Dioma G, Sanon B, Somlaré H, Kyetega A, Ba AK, Aké F, Tarbangdo F, Aboua FA, Donnou Y, Kamaté I, Patel JC, Schmink S, Spiller MW, Topaz N, Novak R, Wang X, Bicaba B, Sangaré L, Ouédraogo-Traoré R, Kristiansen PA. Mbaeyi S, et al. Among authors: congo ouedraogo m. Lancet Infect Dis. 2020 Dec;20(12):1418-1425. doi: 10.1016/S1473-3099(20)30239-5. Epub 2020 Jul 9. Lancet Infect Dis. 2020. PMID: 32653071 Free PMC article.
Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination.
Soeters HM, Kambiré D, Sawadogo G, Ouédraogo-Traoré R, Bicaba B, Medah I, Sangaré L, Ouédraogo AS, Ouangraoua S, Yaméogo I, Congo-Ouédraogo M, Ky Ba A, Aké F, Velusamy S, McGee L, Van Beneden C, Whitney CG. Soeters HM, et al. Among authors: congo ouedraogo m. Vaccine. 2020 Jul 31;38(35):5726-5733. doi: 10.1016/j.vaccine.2020.06.002. Epub 2020 Jun 24. Vaccine. 2020. PMID: 32591290 Free PMC article.
Streptococcus pneumoniae invasive infections in Burkina Faso, 2007 to 2011.
Chaïbou Y, Sanou I, Congo-Ouedraogo M, Kienou MC, Ouattara K, Somlaré H, Traoré AS, Sangaré L. Chaïbou Y, et al. Among authors: congo ouedraogo m. Med Mal Infect. 2014 Mar;44(3):117-22. doi: 10.1016/j.medmal.2014.01.014. Epub 2014 Mar 4. Med Mal Infect. 2014. PMID: 24612507
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018-2019.
Congo-Ouedraogo M, Poncin T, Sangaré L, Mérimèche M, Braille A, Jacquier H, Ouedraogo AS, Dah E, Traore I, Corander J, Haukka K, Berçot B, Godreuil S. Congo-Ouedraogo M, et al. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e565-e568. doi: 10.1111/jdv.18037. Epub 2022 Mar 8. J Eur Acad Dermatol Venereol. 2022. PMID: 35224783 No abstract available.
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
Eholie SP, Moh R, Benalycherif A, Gabillard D, Ello F, Messou E, Zoungrana J, Diallo I, Diallo M, Bado G, Cisse M, Maiga AI, Anzian A, Toni TD, Congo-Ouedraogo M, Toure-Kane C, Seydi M, Minta DK, Sawadogo A, Sangaré L, Drabo J, Karcher S, Le Carrou J, de Monteynard LA, Peytavin G, Gabassi A, Girard PM, Chaix ML, Anglaret X, Landman R; Thilao ANRS 12269 Study Group. Eholie SP, et al. Among authors: congo ouedraogo m. Lancet HIV. 2019 Nov;6(11):e750-e759. doi: 10.1016/S2352-3018(19)30228-0. Epub 2019 Oct 7. Lancet HIV. 2019. PMID: 31601544